Form 4: XOMA Royalty Corp: Chief Investment Officer Bradley Sitko Reports Securities Transactions
SEC Form 4 Filing
Chief Investment Officer Bradley Sitko reports the acquisition and disposal of XOMA Royalty Corp securities, including Depositary Shares and Common Stock.
Summary
- On April 7, 2025, Bradley Sitko, Chief Investment Officer of XOMA Royalty Corp, engaged in transactions involving the company's securities.
- Sitko acquired 2,000 Depositary Shares 8.375% Series B Cumulative Stock at a weighted average price of $24.7 per share.
- The transactions were executed in multiple trades at prices ranging from $24.69 to $24.72.
- Following the reported transactions, Sitko directly owns 5,045 Depositary Shares 8.375% Series B Cumulative Stock, 11,484 shares of Common Stock, and 313 shares of 8.625% Series A Cumulative Perpetual Preferred Stock.
- Sitko also indirectly owns 829 shares of Common Stock through a 401(k) plan, 1,500 shares of Common Stock through a spouse, 75 shares of Common Stock through a child, 75 shares of Common Stock through a child, 82 shares of 8.625% Series A Cumulative Perpetual Preferred Stock through a spouse, and 2,000 Depositary Shares 8.375% Series B Cumulative Stock through a spouse.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard disclosure of insider trading activity.
Positives
- The reporting person increased their holdings in the company through the purchase of Depositary Shares.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
- Similar filings are made by executives at comparable royalty companies like Ligand Pharmaceuticals and Royalty Pharma, disclosing their transactions in company stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by providing insight into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 04/07/2025 | Date of securities transactions |
| 04/09/2025 | Date of signature for the Form 4 filing |
Keywords
XOMA Royalty Corp, Bradley Sitko, securities transactions, Depositary Shares, Common Stock, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.